Source: DGNews  |  Posted 9 years ago

By Adrian Burton

NICE, FRANCE -- October 21, 2002 -- Capecitabine has been found to provide good objective responses, improve time to disease progression, and yield good survival rates in the treatment of patients with advanced gastric cancer. The added advantage is that capecitabine is an orally administered drug and therefore improves patient quality of life, said researchers at the 27th Congress of the European Society for Medical Oncology.

"In general, locally advanced metastatic gastric cancer is incurable," explained Dr. Eucario Le